Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 7, 2024Advanced Therapeutics

Fluorinated Chitosan‐Mediated Transepithelial Delivery of Intravesical Dual‐Drug Immunotherapeutic for Bladder Cancer Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

LFLida FengGHGuixiao HuangQLQifang Lei

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Feng et al. (2024) studied this question.

synapsesocial.com/papers/68e65ab4b6db6435875e920bhttps://doi.org/10.1002/adtp.202400084
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Synergistic intravesical instillation for bladder cancer: CRISPR-Cas13a and fenbendazole combination therapy2024 · 13 citations
  2. 2Mucoadhesive tumor-penetrating nanomedicine for intravesical chemo-immunotherapy against bladder cancer2026 · 1 citations
  3. 3A tumor targeted nano micelle carrying astragaloside IV for combination treatment of bladder cancer2024 · 10 citations
  4. 4NIR‐Activatable Domino Cascade Catalysis Nanozyme Reactor for Multi‐Mechanism Synergistic Immunotherapy in Bladder Cancer2025
  5. 5Enhancing Therapeutic Efficacy and Safety of Immune Checkpoint Inhibition for Bladder Cancer: A Comparative Analysis of Injectable vs. Intravesical Administration2024 · 5 citations